SCHEMBL12534477

SCHEMBL12534477

COc1cc(OC[C@@H]2CNCCO2)c(NC(=O)Nc2cnc(C#N)cn2)cc1C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 20/20 0.67
▸ KCNH2 Q12809 2/20 0.65
▸ FECH P22830 1/20 0.65
▸ FLT4 P35916 4/20 0.60
▸ GSK3B P49841 4/20 0.60
▸ RPS6KA3 P51812 4/20 0.60
▸ AURKA O14965 3/20 0.60
▸ MAP4K4 O95819 2/20 0.60
▸ RET P07949 2/20 0.60
▸ CLK2 P49760 2/20 0.60
▸ IRAK1 P51617 2/20 0.60
▸ BRSK1 Q8TDC3 2/20 0.60
▸ SRPK1 Q96SB4 2/20 0.60
▸ MAP4K5 Q9Y4K4 2/20 0.60
▸ CDK2 P24941 2/20 0.60
▸ MAPKAPK2 P49137 2/20 0.60
▸ IKBKB O14920 1/20 0.60
▸ DCLK1 O15075 1/20 0.60
▸ RPS6KA5 O75582 1/20 0.60
▸ PRKD3 O94806 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10083991 0.93 CHEK1 (0.71) CHEK1KCNH2FECHFLT4GSK3B
SCHEMBL305186 0.92 CHEK1 (0.74) CHEK1KCNH2FECHFLT4GSK3B
SCHEMBL305187 0.92 CHEK1 (0.74) CHEK1KCNH2FECHFLT4GSK3B
SCHEMBL306199 0.91 CHEK1 (0.68) CHEK1KCNH2FECHFLT4GSK3B
SCHEMBL306200 0.91 CHEK1 (0.68) CHEK1KCNH2FECHFLT4GSK3B
SCHEMBL305570 0.88 CHEK1 (0.63) CHEK1KCNH2FECHFLT4GSK3B
Hydrochloric Acid SCHEMBL306016 0.87 CHEK1 (0.62) CHEK1KCNH2FECHFLT4GSK3B
SCHEMBL304807 0.84 CHEK1 (0.68) CHEK1KCNH2FECHFLT4GSK3B
SCHEMBL304808 0.84 CHEK1 (0.68) CHEK1KCNH2FECHFLT4GSK3B
SCHEMBL305203 0.83 CHEK1 (0.86) CHEK1KCNH2FECHFLT4GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2330105-A1 Heteroaryl urea derivatives useful for inhibiting CHK1 ICOS Corporation (US) 2011-06-08 — — EP disclosed
Send feedback